| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |